Detalhe da pesquisa
1.
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants.
NPJ Vaccines
; 9(1): 41, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383584
2.
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months.
Hum Vaccin Immunother
; 18(6): 2146435, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36412272
3.
Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes.
Bull World Health Organ
; 91(1): 75-8, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23397354